US Stocks
/
Nektar Therapeutics Share Price
Nektar Therapeutics Share Price

Nektar Therapeutics Share Price

NASDAQ: NKTR | Small Cap
$41.14
+$0.18 (0.44%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Nektar Therapeutics Stock Performance

Open
$40.63
Prev. Close
$40.96
Circuit Range
N/A
Day Range
$40.51 - $42.23
Year Range
$33.58 - $108.83
Volume
38,922
Average Traded
$41.30

Nektar Therapeutics Share Price Today

As of 10 October 2026, Nektar Therapeutics's share price is $41.14. The stock opened at $40.63, compared to its previous close of $40.96. During today's trading session, Nektar Therapeutics's share price traded between $40.51 and $42.23, with an average price of $41.37. Over the past 52 weeks, the stock has recorded a high of $108.83 and a low of $33.58. In terms of performance, Nektar Therapeutics's share price has declined by 51.65% over the last six months and is down 36.61% on a year-on-year basis.

Nektar Therapeutics Share Price Chart

$40.51$42.23
L
Show Current Price
H

Nektar Therapeutics Stock Fundamentals & Key Indicators

Market Cap
$694.07M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.60
Revenue (TTM)
$55.23B
Return On Equity (TTM)
-17.40%
Profit Margin
-297.08%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-14.36%

Nektar Therapeutics Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$11.79$21.81$10.86$10.13
Net Profit-$35.52-$36.08-$44.90-$40.62
Net Profit Margin-301.27%-165.43%-413.44%-400.99%
Income ChangeN/A-1.58%-24.45%9.53%

Nektar Therapeutics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$92.06$90.12$98.43$55.23
Net Profit-$368.20-$276.06-$118.96-$164.08
Net Profit Margin-399.96%-306.32%-120.86%-297.08%
Income ChangeN/A25.02%56.91%-37.93%

About Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Nektar Therapeutics Historical Returns

MonthOpenCloseChange %
Oct 2026
$55.45
$41.23
-32.04%
Sep 2026
$72.06
$60.67
-18.59%
Aug 2026
$69.28
$74.53
+5.43%
Jul 2026
$68.80
$70.69
+1.33%
Jun 2026
$64.50
$69.76
+7.62%
May 2026
$85.00
$64.82
-23.81%
Apr 2026
$72.59
$85.08
+18.31%
Mar 2026
$68.56
$71.92
+4.33%
Feb 2026
$38.18
$68.93
+84.55%
Jan 2026
$42.62
$37.35
-11.61%
Dec 2025
$64.31
$42.26
-35.08%
Nov 2025
$62.41
$65.09
+0.29%

NKTR Share Price FAQs

What is Nektar Therapeutics share price today?

chevron-up
Nektar Therapeutics share price today is $41.14 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Nektar Therapeutics stock?

chevron-up
The 52 week high of Nektar Therapeutics stock is $108.83, while the 52 week low is $33.58 as of 10 Oct '26.

What is NKTR's market capitalisation today?

chevron-up
NKTR market capitalisation is $694.07M as of October 10, 2026, at 6:22 pm IST.

What is NKTR's net income for the last quarter?

chevron-up
NKTR's net income for the last quarter is -40.62B USD.

What is the 5 year returns of NKTR?

chevron-up
The 5 year returns of NKTR is -81.91% as on 10 Oct '26.

What is the high & low stock price of NKTR today?

chevron-up
NKTR stock price hit a high of $42.23 and low of $40.51 as of 10 Oct '26.

Can I buy NKTR shares in India?

chevron-up
Yes. You can buy NKTR in India by opening an international trading account.